LT2892911T - Oleanolinės rūgšties c17 heteroarilo dariniai ir jų panaudojimo būdas - Google Patents

Oleanolinės rūgšties c17 heteroarilo dariniai ir jų panaudojimo būdas

Info

Publication number
LT2892911T
LT2892911T LTEP13767175.6T LT13767175T LT2892911T LT 2892911 T LT2892911 T LT 2892911T LT 13767175 T LT13767175 T LT 13767175T LT 2892911 T LT2892911 T LT 2892911T
Authority
LT
Lithuania
Prior art keywords
methods
oleanolic acid
heteroaryl derivatives
heteroaryl
derivatives
Prior art date
Application number
LTEP13767175.6T
Other languages
English (en)
Lithuanian (lt)
Inventor
Xin Jiang
Christopher F. BENDER
Melean Visnick
Original Assignee
Reata Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reata Pharmaceuticals, Inc. filed Critical Reata Pharmaceuticals, Inc.
Publication of LT2892911T publication Critical patent/LT2892911T/lt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/101,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Lubricants (AREA)
  • Steroid Compounds (AREA)
  • Epidemiology (AREA)
LTEP13767175.6T 2012-09-10 2013-09-10 Oleanolinės rūgšties c17 heteroarilo dariniai ir jų panaudojimo būdas LT2892911T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261699199P 2012-09-10 2012-09-10
PCT/US2013/059015 WO2014040056A1 (en) 2012-09-10 2013-09-10 C17-heteroaryl derivatives of oleanolic acid and methods of use thereof

Publications (1)

Publication Number Publication Date
LT2892911T true LT2892911T (lt) 2017-11-10

Family

ID=49253401

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP13767175.6T LT2892911T (lt) 2012-09-10 2013-09-10 Oleanolinės rūgšties c17 heteroarilo dariniai ir jų panaudojimo būdas

Country Status (28)

Country Link
US (1) US20140088163A1 (enExample)
EP (1) EP2892911B1 (enExample)
JP (1) JP6272870B2 (enExample)
KR (1) KR102237364B1 (enExample)
CN (1) CN104768965B (enExample)
AU (1) AU2013312102B2 (enExample)
BR (1) BR112015005200B1 (enExample)
CA (1) CA2882417C (enExample)
CY (1) CY1119762T1 (enExample)
DK (1) DK2892911T3 (enExample)
EA (1) EA029069B1 (enExample)
ES (1) ES2644615T3 (enExample)
HR (1) HRP20171565T1 (enExample)
HU (1) HUE036797T2 (enExample)
IL (1) IL237638B (enExample)
IN (1) IN2015DN01547A (enExample)
LT (1) LT2892911T (enExample)
ME (1) ME02911B (enExample)
MX (1) MX366954B (enExample)
NZ (1) NZ705213A (enExample)
PL (1) PL2892911T3 (enExample)
PT (1) PT2892911T (enExample)
RS (1) RS56563B1 (enExample)
SG (1) SG11201501800UA (enExample)
SI (1) SI2892911T1 (enExample)
SM (1) SMT201700501T1 (enExample)
WO (1) WO2014040056A1 (enExample)
ZA (1) ZA201501203B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104739841B (zh) 2008-01-11 2018-06-01 里亚塔医药公司 合成三萜类化合物及用以治病之方法
US8124799B2 (en) 2008-04-18 2012-02-28 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17
BRPI0911105B1 (pt) 2008-04-18 2022-11-08 Reata Pharmaceuticals, Inc Compostos contendo um farmacóforo anti-inflamatório, composição farmacêutica, bem como seus usos
ME02973B (me) 2010-12-17 2018-07-20 Reata Pharmaceuticals Inc Pirazolil i pirimidinil triciklični enoni kao antioksidantni modulatori inflamacije
PT3444261T (pt) 2012-04-27 2021-03-12 Reata Pharmaceuticals Inc Derivados de 2,2-difluoropropionamida de metil bardoxolona, formas polimorfas e métodos de uso dos mesmos
US9556222B2 (en) 2012-06-15 2017-01-31 Reata Pharmaceuticals, Inc. A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof
TWI630212B (zh) 2012-09-10 2018-07-21 瑞塔醫藥有限責任公司 丁香油素(oleanolic acid)之c17-烷二基與烯二基衍生物及其使用方法
US9512094B2 (en) 2012-09-10 2016-12-06 Reata Pharmaceuticals, Inc. C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
UY39092A (es) 2013-04-24 2021-03-26 Abbvie Inc Derivados de 2,2-difluoropropanamida y metil bardoxolona, formas polimórficas y métodos de uso
WO2016130927A1 (en) 2015-02-12 2016-08-18 Reata Pharmaceuticals, Inc. Imidazolyl tricyclic enones as antioxidant iflammation modulators
AU2016326704B2 (en) 2015-09-23 2021-01-28 Reata Pharmaceuticals, Inc. C4-modified oleanolic acid derivatives for inhibition of IL-17 and other uses
BR112019009256A2 (pt) 2016-11-08 2019-07-16 Reata Pharmaceuticals Inc métodos para tratar síndrome de alport usando bardoxolona metil ou análogos do mesmo
CN106632574B (zh) * 2016-12-07 2018-05-29 广东天键生物科技有限公司 一种化合物、其制备方法及用途
TWI831738B (zh) 2016-12-16 2024-02-11 美商瑞塔醫藥有限責任公司 用於抑制RORγ及其他用途的嘧啶三環烯酮衍生物
RU2758376C2 (ru) 2017-09-14 2021-10-28 Феникс Байотекнолоджи, Инк. Способ и улучшенная нейропротекторная композиция для лечения неврологических патологических состояний
JP6820450B2 (ja) 2017-09-14 2021-01-27 フェニックス・バイオテクノロジー・インコーポレイテッド ウイルス感染を治療するための方法および組成物
CA3103726A1 (en) 2018-06-15 2019-12-19 Reata Pharmaceuticals, Inc. Pyrazole and imidazole compounds for inhibition of il-17 and rorgamma
WO2019246461A1 (en) 2018-06-20 2019-12-26 Reata Pharmaceuticals, Inc. Cysteine-dependent inverse agonists of nuclear receptors ror-gamma/ror-gamma-t and methods of treating diseases or disorders therewith
CA3114354A1 (en) * 2018-09-28 2020-04-02 Sichuan Haisco Pharmaceutical Co., Ltd. Terpinoid derivatives and uses thereof
AU2020316351A1 (en) * 2019-07-19 2022-02-17 Reata Pharmaceuticals, Inc. C17 polar-substituted heteroaromatic synthetic triterpenoids and methods of use thereof
EP4009981B1 (en) 2020-03-31 2023-08-16 Phoenix Biotechnology, Inc. Method and compositions for treating coronavirus infection
WO2021201903A1 (en) 2020-03-31 2021-10-07 Phoenix Biotechnology, Inc. Method and compositions for treating coronavirus infection
JP7214696B2 (ja) * 2020-10-01 2023-01-30 一般財団法人 化学物質評価研究機構 新規in vitro皮膚感作性試験法
WO2022126129A1 (en) 2020-12-11 2022-06-16 Reata Pharmaceuticals, Inc. Synthetic triterpenoids for use in therapy
CN117015548A (zh) 2021-01-18 2023-11-07 里亚塔医药公司 合成的熊果酸衍生物和其使用方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6326507B1 (en) * 1998-06-19 2001-12-04 Trustees Of Dartmouth College Therapeutic compounds and methods of use
CA2485565A1 (en) * 2002-05-13 2004-08-05 Trustees Of Dartmouth College Inhibitors and methods of use thereof
CN104739841B (zh) 2008-01-11 2018-06-01 里亚塔医药公司 合成三萜类化合物及用以治病之方法
WO2009146216A2 (en) 2008-04-18 2009-12-03 Reata Pharmaceuticals. Inc. Antioxidant inflammation modulators: novel derivatives of oleanolic acid
CA2721666C (en) * 2008-04-18 2017-05-23 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: c-17 homologated oleanolic acid derivatives
US8124799B2 (en) * 2008-04-18 2012-02-28 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17
TWI442925B (zh) * 2008-04-18 2014-07-01 Reata Pharmaceuticals Inc 抗氧化性發炎調節劑:c-環飽和之齊墩果酸衍生物
UY33946A (es) * 2011-03-11 2012-08-31 Reata Pharmaceuticals Inc Derivados de c4-monometil triterpenoides y sus métodos de uso
US9556222B2 (en) * 2012-06-15 2017-01-31 Reata Pharmaceuticals, Inc. A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof

Also Published As

Publication number Publication date
WO2014040056A1 (en) 2014-03-13
MX366954B (es) 2019-07-31
BR112015005200B1 (pt) 2022-07-05
ZA201501203B (en) 2021-08-25
SI2892911T1 (sl) 2017-12-29
IL237638B (en) 2020-04-30
HUE036797T2 (hu) 2018-07-30
KR20150053982A (ko) 2015-05-19
HK1211295A1 (en) 2016-05-20
AU2013312102B2 (en) 2018-03-08
AU2013312102A1 (en) 2015-03-12
IN2015DN01547A (enExample) 2015-07-03
JP2015529227A (ja) 2015-10-05
BR112015005200A2 (enExample) 2017-08-15
ES2644615T3 (es) 2017-11-29
RS56563B1 (sr) 2018-02-28
US20140088163A1 (en) 2014-03-27
KR102237364B1 (ko) 2021-04-06
IL237638A0 (en) 2015-04-30
CA2882417C (en) 2021-04-20
ME02911B (me) 2018-10-20
EA201590539A1 (ru) 2015-08-31
DK2892911T3 (en) 2017-10-23
CN104768965B (zh) 2018-05-11
EA029069B1 (ru) 2018-02-28
PL2892911T3 (pl) 2018-03-30
NZ705213A (en) 2018-07-27
SG11201501800UA (en) 2015-04-29
JP6272870B2 (ja) 2018-01-31
MX2015003078A (es) 2015-07-14
PT2892911T (pt) 2017-11-02
CN104768965A (zh) 2015-07-08
SMT201700501T1 (it) 2017-11-15
CY1119762T1 (el) 2018-06-27
CA2882417A1 (en) 2014-03-13
HRP20171565T1 (hr) 2017-12-15
EP2892911A1 (en) 2015-07-15
EP2892911B1 (en) 2017-08-30

Similar Documents

Publication Publication Date Title
IL237638B (en) Heteroaryl c17 derivatives of olanolic acid and methods of using them
IL237639A0 (en) Alkanedial and alkanedial derivatives at the 17th carbon position of oleinolic acid and methods of using them
SI2683731T1 (sl) C4-monometil triterpenoidni derivati in postopki njihove uporabe
SG10201609940RA (en) Compounds and their methods of use
IL238662A0 (en) Bendamustine derivatives and methods of using them
SG11201501381PA (en) Topical compositions and methods of use
IL236965B (en) Derivatives of 5-aminolevulinic acid and uses thereof
IL234841A0 (en) Administration forms of halofuginone and methods of use
ZA201503171B (en) Modified hyaluronic acid derivatives and use thereof
EP2986112A4 (en) PREPARATION AND USE OF FULVINIC ACID DERIVATIVES
EP3004069A4 (en) HUMINIC ACID DERIVATIVES AND METHOD FOR THE PREPARATION AND USE
ZA201408128B (en) Etract of greyia radlkoferi and use thereof
IL238934A0 (en) Methods for the preparation of phenyloxymethyl-nitro-imidazole derivatives and their use
GB201222768D0 (en) Preparation and analysis of iminosugar acids